Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection
NCT04915586Completed
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tissue-plasminogen activator and dornase alfa in pleural infection and empyema, sponsored by Universiti Kebangsaan Malaysia. Primary endpoint: Radiographic improvement in pleural opacity on chest radiograph at Day 7. Started Dec 2019; status: completed.
02
Drugs
tissue-plasminogen activatordornase alfa
03
Conditions
pleural infectionempyema
Beyond the preview
Go deeper on NCT04915586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04915586.